[Back]
Univ.-Prof. Mag. Dr. Gerhard Ecker
Gerhard Ecker
T: +43-1-4277-55110
http://pharminfo.univie.ac.at

Consultation hours: Wed 14:00 - 15:00, 2E405 or online, registration per E-mail at latest till Friday the week before

Winter term 2024
301800 VO MPM 1 - Lecture Course: Fundamentals of DNA replication and sources of DNA damage, - including defective DNA repair mechanisms, in the context of signature diseases
321001 VO Steop Einführung in die pharmazeutischen Wissenschaften - B1
321005 VO Grundlagen der physikalischen Chemie - B3
321007 VO Statistik für PharmazeutInnen - BA7 - B3
321028 VO Pharmazeutische Chemie 1 - B15
322001 VO (Bio)pharma. mit Wirkung auf metabol. Störungen & eingeschr. Organ- und Systemfunktionen - M1
322002 VO Antiinfektiva, Antineoplastika und (Bio)pharmazeutika mit Wirkung auf das Immunsystem - M2
322026 VU Ausgewählte Kapitel aus der pharmazeutisch-chemischen Forschung - M13
323003 VO Basics of Drug Discovery - MPS2
323005 VO Preclinical Drug Development - MPS4
Summer term 2024
301817 UE MPM 6 - Practical Course: Pharmacoinformatics and structure-based drug design
321029 VO Pharmazeutische Chemie 2 - B15
322005 VO (Bio)pharmazeutika mit Wirkung auf das Herz-Kreislauf System - M4
322006 VO (Bio)pharmazeutika mit Wirkung auf das Nervensystem - M5
322022 VU Ausgewählte Kapitel aus der pharmazeutisch-chemischen Forschung - M13
323101 VU Pharmacoinformatics - MPS5
323102 VU Pharmacoinformatics Practical Course - MPS5
Winter term 2023
301800 VO MPM 1 - Lecture Course: Fundamentals of DNA replication and sources of DNA damage, - including defective DNA repair mechanisms, in the context of signature diseases
321001 VO Steop Einführung in die pharmazeutischen Wissenschaften - B1
321005 VO Grundlagen der physikalischen Chemie - B3
321028 VO Pharmazeutische Chemie 1 - B15
322001 VO (Bio)pharma. mit Wirkung auf metabol. Störungen & eingeschr. Organ- und Systemfunktionen - M1
322002 VO Antiinfektiva, Antineoplastika und (Bio)pharmazeutika mit Wirkung auf das Immunsystem - M2
322022 VU Ausgewählte Kapitel aus der pharmazeutisch-chemischen Forschung - M13
323003 VO Basics of Drug Discovery - MPS2
323005 VO Preclinical Drug Development - MPS4
950210 VO VO Einführung in die Klinische Pharmazie
1 - 20 out of 342
Li E, Boujeddaine N, Houtman MJC, Maas, Sluijter , Ecker G et al. Development of new Kir2.1 channel openers from propafenone analogues. British Journal of Pharmacology. 2024 Oct 17.
Digles D, Ingles-Prieto A, Dvorak V, Mocking TAM, Goldmann U, Garofoli A et al. Advancing drug discovery through assay development: a survey of tool compounds within the human solute carrier superfamily. Frontiers in Pharmacology. 2024 Jul 9;15:1401599. doi: 10.3389/fphar.2024.1401599
Granulo N, Sosnin S, Digles D, Ecker GF. The macrocycle inhibitor landscape of SLC‐transporter. Molecular Informatics. 2024 May;43(5):e202300287. Epub 2024 Jan 30. doi: 10.1002/minf.202300287
Huang J, Osthushenrich T, MacNamara A, Mälarstig A, Brocchetti S, Bradberry S et al. ProteoMutaMetrics: machine learning approaches for solute carrier family 6 mutation pathogenicity prediction. Rsc advances. 2024 Apr 22;14(19):13083-13094. 00748. doi: 10.1039/d4ra00748d
Ferrada E, Wiedmer T, Wang WA, Frommelt F, Steurer B, Klimek C et al. Experimental and Computational Analysis of Newly Identified Pathogenic Mutations in the Creatine Transporter SLC6A8. Journal of Molecular Biology. 2024 Jan 15;436(2):168383. doi: 10.1016/j.jmb.2023.168383
Helmke P, Füzi B, Ecker GF. Bioactivity descriptors for in vivo toxicity prediction: now and the future. Expert Opinion on Drug Metabolism and Toxicology. 2024;20(7):541-543. doi: 10.1080/17425255.2024.2334308
Grandits M, Ecker GF. Ligand- and Structure-based Approaches for Transmembrane Transporter Modeling. Current drug research reviews. 2024;16(2):81-93. Epub 2023. doi: 10.2174/2589977515666230508123041
Smajić A, Grandits M, Ecker GF. Privacy-preserving techniques for decentralized and secure machine learning in drug discovery. Drug Discovery Today. 2023 Dec;28(12):1-8. 103820. Epub 2023 Nov 5. doi: 10.1016/j.drudis.2023.103820
Grillberger K, Cöllen E, Trivisani CI, Blum J, Leist M, Ecker G. Structural Insights into Neonicotinoids and N-Unsubstituted Metabolites on Human nAChRs by Molecular Docking, Dynamics Simulations, and Calcium Imaging. International Journal of Molecular Sciences. 2023 Aug 24;24(17):13170. doi: 10.3390/ijms241713170
Smajić A, Rami I, Sosnin S, Ecker GF. Identifying Differences in the Performance of Machine Learning Models for Off-Targets Trained on Publicly Available and Proprietary Data Sets. Chemical Research in Toxicology. 2023 Aug 21;36(8):1300-1312. Epub 2023 Jul 13. doi: 10.1021/acs.chemrestox.3c00042
Dvorak V, Casiraghi A, Colas C, Koren A, Tomek T, Offensperger F et al. Paralog-dependent isogenic cell assay cascade generates highly selective SLC16A3 inhibitors. Cell Chemical Biology. 2023 Aug 17;30(8):953-964.e9. doi: 10.1016/j.chembiol.2023.06.029
Sanz F, Pognan F, Steger-Hartmann T, Díaz C, Asakura S, Amberg A et al. eTRANSAFE: data science to empower translational safety assessment. Nature Reviews. Drug Discovery. 2023 Aug;22(8):605-606. doi: 10.1038/d41573-023-00099-5
Füzi B, Mathai N, Kirchmair J, Ecker GF. Toxicity prediction using target, interactome, and pathway profiles as descriptors. Toxicology Letters. 2023 May 15;381:20-26. doi: 10.1016/j.toxlet.2023.04.005
Huang J, Ecker G. A Structure-Based View on ABC-Transporter Linked to Multidrug Resistance. Molecules. 2023 Jan 4;28(2):494. 495. doi: 10.3390/molecules28020495
van der Noord VE, van der Stel W, Louwerens G, Verhoeven D, Kuiken HJ, Lieftink C et al. Systematic screening identifies ABCG2 as critical factor underlying synergy of kinase inhibitors with transcriptional CDK inhibitors. Breast Cancer Research. 2023;25(1):51. 51. doi: 10.1186/s13058-023-01648-x
Schrempf A, Bernardo S, Arasa Verge EA, Ramirez Otero MA, Wilson J, Kirchhofer D et al. POLθ processes ssDNA gaps and promotes replication fork progression in BRCA1-deficient cells. Cell Reports. 2022 Nov 29;41(9):111716. doi: 10.1016/j.celrep.2022.111716
Smajic A, Grandits M, Ecker GF. Using Jupyter Notebooks for re-training machine learning models. Journal of Cheminformatics. 2022 Aug 13;14(1):54. doi: 10.1186/s13321-022-00635-2
Naga D, Parrott N, Ecker GF, Olivares-Morales A. Evaluation of the Success of High-Throughput Physiologically Based Pharmacokinetic (HT-PBPK) Modeling Predictions to Inform Early Drug Discovery. Molecular Pharmaceutics. 2022 Jul 4;19(7):2203-2216. Epub 2022 Apr 27. doi: 10.1021/acs.molpharmaceut.2c00040
Decker S, Taschauer A, Geppl E, Pirhofer V, Schauer M, Pöschl S et al. Structure-based peptide ligand design for improved epidermal growth factor receptor targeted gene delivery. European Journal of Pharmaceutics and Biopharmaceutics. 2022 Jul;176:211-221. doi: 10.1016/j.ejpb.2022.05.004
Füzi B, Malik-Sheriff RS, Manners EJ, Hermjakob H, Ecker GF. KNIME workflow for retrieving causal drug and protein interactions, building networks, and performing topological enrichment analysis demonstrated by a DILI case study. Journal of Cheminformatics. 2022 Jun 13;14(1):37. doi: 10.1186/s13321-022-00615-6
1 - 20 out of 342

Prediction of Toxicity - let's use Fingerprints

Gerhard Ecker (Speaker)

29 Nov 2024

Activity: Talks and presentations › Talk or oral contribution › Science to Science

In silica prediction of toxicity - from QSAR models to biological fingerprinting

Gerhard Ecker (Speaker)

25 Oct 2023

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Predicting chemicals' Molecular Initiating Events (MIEs) based on protein structure

Gerhard Ecker (Speaker)

25 Nov 2022

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Structure-based prediction of molecular initiating events - where are we?

Gerhard Ecker (Speaker)

29 Sept 2022

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Transporter Informatics and Computational Toxicology - from QSAR to Machine Learning and beyond

Gerhard Ecker (Speaker)

7 Sept 2022

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Wie lassen sich Elternschaft und Wissenschaft vereinbaren?

Veronika Wöhrer (Speaker), Gerhard Ecker (Speaker), Therese Garstenauer (Speaker), Benjamin Herr (Speaker) & Alice Leal (Speaker)

13 Jun 2022

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Arzneistoffentwicklung in Zeiten personalisierter Medizin

Gerhard Ecker (Speaker)

19 Jun 2021

Activity: Talks and presentations › Talk or oral contribution › Science to Science

In silico Toxicology - from prediction of transporter interaction profiles to toxicological read across and beyond

Gerhard Ecker (Speaker)

20 May 2019

Activity: Talks and presentations › Talk or oral contribution › Science to Science

The OMICS approach - the buzz that makes the world go round

Gerhard Ecker (Speaker)

27 Mar 2019

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Upsampling of Molecules to create datasets large enough for Deep learning in toxicity prediction

Jennifer Hemmerich (Speaker), Ece Asilar (Contributor) & Gerhard Ecker (Contributor)

12 Nov 2018

Activity: Talks and presentations › Talk or oral contribution › Science to Science

DEEPHUNT: HEPATOTOXICITY USING NEURAL NETWORKS.

Ece Asilar (Speaker), Jennifer Hemmerich (Contributor) & Gerhard Ecker (Contributor)

20 Sept 2018

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Exploring the use of neural networks for prediction of toxicities

Jennifer Hemmerich (Speaker), Ece Asilar (Contributor) & Gerhard Ecker (Contributor)

21 Jul 2018

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Predicting ligand residence time - it's all about how long you stay

Gerhard Ecker (Speaker)

4 Jul 2018

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Leveraging integrated life science data – the power of workflows

Gerhard Ecker (Speaker)

19 Mar 2018

Activity: Talks and presentations › Talk or oral contribution › Science to Science

In silico Toxicology - from prediction of transporter interaction profiles to toxicological read across and beyond

Gerhard Ecker (Invited speaker)

13 Mar 2018

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Linking open data - from transporter interaction profiles to toxicity prediction

Gerhard Ecker (Invited speaker)

20 Sept 2017

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Predicting drug residence time - its all about how long you stay

Gerhard Ecker (Invited speaker)

18 Sept 2017

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Open PHACTS - Exploiting semantically integrated life science data for transporter profiling

Gerhard Ecker (Invited speaker)

7 Aug 2017

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Leveraging linked open data - from transporter interaction profiling to toxicity prediction and beyond

Gerhard Ecker (Invited speaker)

23 May 2017

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Innovative Medicines Initiative - From semantic data integration to risk assessment

Gerhard Ecker (Invited speaker)

5 Apr 2017

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Leveraging open data for development of ABC-transporter inhibitors

Gerhard Ecker (Invited speaker)

27 Mar 2017

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Leveraging linked open data - from transporter profiling to toxicity prediction and beyond

Gerhard Ecker (Invited speaker)

21 Mar 2017

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Leveraging linked open data - from transporter interaction profiling to toxicity prediction and beyond

Gerhard Ecker (Invited speaker)

15 Mar 2017

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Exploiting semantically integrated life science data - from transporter profiling to toxicity prediction

Gerhard Ecker (Invited speaker)

9 Feb 2017

Activity: Talks and presentations › Talk or oral contribution › Science to Science

The power of open data - linking transporter interaction profiles to in vivo toxicity

Gerhard Ecker (Invited speaker)

3 Feb 2017

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Leveraging linked open data - from transporter interaction profiles to toxicity prediction

Gerhard Ecker (Invited speaker)

19 Jan 2017

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Open Innovation in the Age of Big Data

Gerhard Ecker (Invited speaker)

17 Nov 2016

Activity: Talks and presentations › Talk or oral contribution › Other

Exploiting Linked Open Data - the Power of Workflows

Gerhard Ecker (Invited speaker)

12 Apr 2016

Activity: Talks and presentations › Talk or oral contribution › Other

Quantitative structure-kinetics relationships - can we predict on and off-kinetics?

Gerhard Ecker (Invited speaker)

4 Nov 2014

Activity: Talks and presentations › Talk or oral contribution › Other

the Open PHACTS Discovery Platform - Semantic data integration in Pharmacoinformatics

Gerhard Ecker (Invited speaker)

26 Sept 2014

Activity: Talks and presentations › Talk or oral contribution › Other

It's all about integration - from docking to structure-based classification and prediction of side effects

Gerhard Ecker (Invited speaker)

10 Sept 2014

Activity: Talks and presentations › Talk or oral contribution › Other

The Open PHACTS Discovery Platform - Semantic data integration for medicinal chemists

Gerhard Ecker (Invited speaker)

8 Sept 2014

Activity: Talks and presentations › Talk or oral contribution › Other

Open PHACTS - the use of open data for in silico models

Gerhard Ecker (Invited speaker)

4 Sept 2014

Activity: Talks and presentations › Talk or oral contribution › Other

Exploiting integrated open data in drug discovery

Gerhard Ecker (Invited speaker)

9 May 2014

Activity: Talks and presentations › Talk or oral contribution › Other

It's all about integration - From docking poses to structure-based classification and prediction of side effects

Gerhard Ecker (Invited speaker)

25 Apr 2014

Activity: Talks and presentations › Talk or oral contribution › Other

Open PHACTS - Building an open pharmacological space

Gerhard Ecker (Invited speaker)

3 Apr 2014

Activity: Talks and presentations › Talk or oral contribution › Other

Experimental data guided docking for elucidating the molecular basis of drug-transporter interaction

Gerhard Ecker (Invited speaker)

18 Dec 2013

Activity: Talks and presentations › Talk or oral contribution › Other

Experimental data guided docking allows to elucidate the molecular basis of drug-transporter interaction

Gerhard Ecker (Invited speaker)

4 Dec 2013

Activity: Talks and presentations › Talk or oral contribution › Other

Arzneistoffdesign am computer - Spielerei oder Wissenschaft

Gerhard Ecker (Speaker)

27 Oct 2013

Activity: Talks and presentations › Talk or oral contribution › Other

Computational Drug Design

Gerhard Ecker (Keynote speaker)

24 Jul 2013

Activity: Talks and presentations › Talk or oral contribution › Other

Integrated approaches - from docking poses to prediction of side effects

Gerhard Ecker (Keynote speaker)

1 Jul 2013

Activity: Talks and presentations › Talk or oral contribution › Other

Exploiting open data - a new era in pharmacoinformatics

Gerhard Ecker (Invited speaker)

22 May 2013

Activity: Talks and presentations › Talk or oral contribution › Other

Open PHACTS - a novel platform for integrated data-driven drug discovery

Gerhard Ecker (Invited speaker)

20 Mar 2013

Activity: Talks and presentations › Talk or oral contribution › Other

Arzneistoffentwicklung am Computer - Fact or Fiction?

Gerhard Ecker (Invited speaker)

8 Mar 2013

Activity: Talks and presentations › Talk or oral contribution › Other

Pharmacoinformatics - from data integration to in silico screening

Gerhard Ecker (Speaker)

1 Mar 2013

Activity: Talks and presentations › Talk or oral contribution › Other

The medicinal chemistry of drug transport – knowledge based ligand design.

Gerhard Ecker (Speaker)

28 Nov 2012

Activity: Talks and presentations › Talk or oral contribution › Other

Ligand efficiency and lipophilic efficiency – versatile parameters for the design of inhibitors of transmembrane transporters?

Gerhard Ecker (Speaker)

24 Sept 2012

Activity: Talks and presentations › Talk or oral contribution › Other

The molecular basis of drug-transporter interaction - science or fiction?

Gerhard Ecker (Speaker)

12 Jul 2012

Activity: Talks and presentations › Talk or oral contribution › Other

Arzneistofftransporter und ihre Rolle in der Pharmaforschung

Gerhard Ecker (Speaker)

21 Jun 2012

Activity: Talks and presentations › Talk or oral contribution › Other

Drug Transporters – Structure, Function, and Modulation

Gerhard Ecker (Speaker)

21 Mar 2012

Activity: Talks and presentations › Talk or oral contribution › Other

Knowledge driven ligand design – ligand-based design meets protein structures

Gerhard Ecker (Speaker)

7 Mar 2012

Activity: Talks and presentations › Talk or oral contribution › Other

Ligand- and structure-based approaches for targeting drug transporter

Gerhard Ecker (Invited speaker)

20 Sept 2010

Activity: Talks and presentations › Talk or oral contribution › Other

Experimental data guided ligand docking - a versatile approach for elucidating the molecular basis of drug/transporter interactions

Gerhard Ecker (Invited speaker)

3 Sept 2010

Activity: Talks and presentations › Talk or oral contribution › Other

Computational drug design - where are we and where to go

Gerhard Ecker (Keynote speaker)

17 Jun 2010

Activity: Talks and presentations › Talk or oral contribution › Other

Prediction of ADMET – from rules to networks

Gerhard Ecker (Invited speaker)

24 May 2010

Activity: Talks and presentations › Talk or oral contribution › Other

The medicinal chemistry of drug transporters

Gerhard Ecker (Invited speaker)

24 Apr 2010

Activity: Talks and presentations › Talk or oral contribution › Other

In silico studies for prediction of substrates and inhibitors of P-glycoprotein.

Gerhard Ecker (Invited speaker)

1 Sept 2009

Activity: Talks and presentations › Talk or oral contribution › Other

The medicinal chemistry of P-glycoprotein – ligand- and target-based studies

Gerhard Ecker (Invited speaker)

1 Aug 2009

Activity: Talks and presentations › Talk or oral contribution › Other

In silico models for classification of ABC-transporter substrates to improve ADMET profiling

Gerhard Ecker (Contributor)

27 Jun 2009

Activity: Talks and presentations › Talk or oral contribution › Other

Pharmacoinformatics – combining experimental pharmaceutical sciences with in silico methods

Gerhard Ecker (Speaker)

9 Jun 2009

Activity: Talks and presentations › Talk or oral contribution › Other

Predicting substrate properties for ABC-Transporter - Safety Sciences on the molecular level

Gerhard Ecker (Invited speaker)

7 May 2009

Activity: Talks and presentations › Talk or oral contribution › Other

SIBAR descriptors and support vector machines for ABCB1 substrate prediction

Gerhard Ecker (Contributor)

16 Apr 2009

Activity: Talks and presentations › Talk or oral contribution › Other

Predicting Ligands of ABC-transporter - a long way to go

Gerhard Ecker (Invited speaker)

13 Mar 2009

Activity: Talks and presentations › Talk or oral contribution › Other

Predicting Interaction with ABC-Transporters involved in ADME

Gerhard Ecker (Keynote speaker)

10 Feb 2009

Activity: Talks and presentations › Talk or oral contribution › Other

Safety Sciences in silico - Analyse unerwünschter Wirkungen durch molekulare Modellierung

Gerhard Ecker (Keynote speaker)

19 Nov 2008

Activity: Talks and presentations › Talk or oral contribution › Other

Optimising ligands for promiscuous targets - a case study for P-glycoprotein inhibitors

Gerhard Ecker (Invited speaker)

20 Oct 2008

Activity: Talks and presentations › Talk or oral contribution › Other

Prediction of ligands of promiscuous targets - safety sciences on the molecular level

Gerhard Ecker (Invited speaker)

20 Oct 2008

Activity: Talks and presentations › Talk or oral contribution › Other

Optimizing Ligands for Promiscuous Targets - A Case Study for P-glycoprotein Inhibitors

Gerhard Ecker (Invited speaker)

26 Sept 2008

Activity: Talks and presentations › Talk or oral contribution › Other

Pharmacoinformatic approaches to target polyspecific proteins

Gerhard Ecker (Invited speaker)

13 Sept 2008

Activity: Talks and presentations › Talk or oral contribution › Other

Use your brain - artificial neural networks in drug discovery

Gerhard Ecker (Invited speaker)

12 Sept 2008

Activity: Talks and presentations › Talk or oral contribution › Other

EUROPIN - A European Pharmacoinformatics Initative

Gerhard Ecker (Invited speaker)

4 Jul 2008

Activity: Talks and presentations › Talk or oral contribution › Other

P-glycoprotein - from inhibitor design to substrate prediction

Gerhard Ecker (Invited speaker)

3 Jul 2008

Activity: Talks and presentations › Talk or oral contribution › Other

Prediction of substrate properties for ABC Drug-Transporter: The challenge continues

Gerhard Ecker (Invited speaker)

19 May 2008

Activity: Talks and presentations › Talk or oral contribution › Other

Classification models for hERG inhibitors by counter-propagation neural networks

Gerhard Ecker (Contributor)

10 Apr 2008

Activity: Talks and presentations › Talk or oral contribution › Other

Pharmacoinformatic approaches to target P-glycoprotein - from inhibitor design to substrate prediction

Gerhard Ecker (Invited speaker)

8 Apr 2008

Activity: Talks and presentations › Talk or oral contribution › Other

EUROPIN - A European Pharmacoinformatics Initative

Gerhard Ecker (Invited speaker)

11 Mar 2008

Activity: Talks and presentations › Talk or oral contribution › Other

Predicting ligands for P-glycoprotein - safety sciences on the molecular level

Gerhard Ecker (Speaker)

29 Feb 2008

Activity: Talks and presentations › Talk or oral contribution › Other

Computermodels for predicting P-glycoprotein substrates - can we guide the lead optimisation process?

Gerhard Ecker (Speaker)

21 Feb 2008

Activity: Talks and presentations › Talk or oral contribution › Other

Linking chemical space to biological space - challenges for high-throughput computing

Gerhard Ecker (Speaker)

31 Jan 2008

Activity: Talks and presentations › Talk or oral contribution › Other

Use your brain - artificial neural networks in drug design

Gerhard Ecker (Speaker)

7 Dec 2007

Activity: Talks and presentations › Talk or oral contribution › Other

Polyspecific proteins - safety sciences on the molecular level

Gerhard Ecker (Speaker)

25 Oct 2007

Activity: Talks and presentations › Talk or oral contribution › Other

P-glycoprotein - design of inhibitors and prediction of substrates

Gerhard Ecker (Speaker)

11 Sept 2007

Activity: Talks and presentations › Talk or oral contribution › Other

Vortrag auf Kongress: Recent developments in physics of fundamental interactions

Gerhard Ecker (Invited speaker)

5 Sept 2007

Activity: Talks and presentations › Talk or oral contribution › Other

Multispecificity of drug transporter - probing inhibitor selectivity for the human drug efflux transporter ABCB1 and ABCG2

Gerhard Ecker (Speaker)

27 Aug 2007

Activity: Talks and presentations › Talk or oral contribution › Other

Chemigenomics and Drug Discovery

Gerhard Ecker (Invited speaker)

9 Jul 2007

Activity: Talks and presentations › Talk or oral contribution › Other

P-glycoprotein - from target to antitarget

Gerhard Ecker (Speaker)

28 Jun 2007

Activity: Talks and presentations › Talk or oral contribution › Other

Predicting ligands for ABC-transporter - structure-based vs ligand-based approaches

Gerhard Ecker (Invited speaker)

25 Jun 2007

Activity: Talks and presentations › Talk or oral contribution › Other

Polyspecific proteins - a challenge in pharmacoinformatics

Gerhard Ecker (Speaker)

22 Jun 2007

Activity: Talks and presentations › Talk or oral contribution › Other

Comparative Analysis of two Different Classifiers for Predicting P-glycoprotein Substrates

Gerhard Ecker (Contributor)

17 Jun 2007

Activity: Talks and presentations › Talk or oral contribution › Other

Machine learning methods for classification and hit identification

Gerhard Ecker (Invited speaker)

3 Jun 2007

Activity: Talks and presentations › Talk or oral contribution › Other

Role of structural models of P-glycoprotein - the prediction of actively transported small molecules

Gerhard Ecker (Invited speaker)

14 Apr 2007

Activity: Talks and presentations › Talk or oral contribution › Other

Von Penicillin bis Viagra : Arzneistoffentwicklung gestern - heute - morgen

Gerhard Ecker (Speaker)

23 Nov 2006

Activity: Talks and presentations › Talk or oral contribution › Other

Von Penicillin bis Viagra : Arzneistoffentwicklung gestern - heute - morgen

Gerhard Ecker (Speaker)

22 Nov 2006

Activity: Talks and presentations › Talk or oral contribution › Other

In silico methods for hit identification and prediction of biological activities

Gerhard Ecker (Speaker)

16 Nov 2006

Activity: Talks and presentations › Talk or oral contribution › Other

Drug efflux pumps - From target to antitarget

Gerhard Ecker (Invited speaker)

15 Nov 2006

Activity: Talks and presentations › Talk or oral contribution › Other

MDR - Multiple Drug Resistance

Gerhard Ecker (Invited speaker)

9 Oct 2006

Activity: Talks and presentations › Talk or oral contribution › Other

Pharmacoinformatic approaches to target the molecular basis of polyspecificity

Gerhard Ecker (Invited speaker)

28 Sept 2006

Activity: Talks and presentations › Talk or oral contribution › Other

ABC-transporter as antitargets

Gerhard Ecker (Invited speaker)

26 Sept 2006

Activity: Talks and presentations › Talk or oral contribution › Other

In silico methods for prediction of P-glycoprotein substrates

Gerhard Ecker (Invited speaker)

30 Aug 2006

Activity: Talks and presentations › Talk or oral contribution › Other

Non-linear methods and machine learning in drug discovery

Gerhard Ecker (Invited speaker)

6 Jul 2006

Activity: Talks and presentations › Talk or oral contribution › Other

In vitro and in silico models for prediction of P-glycoprotein substrates

Gerhard Ecker (Invited speaker)

27 Jun 2006

Activity: Talks and presentations › Talk or oral contribution › Other

A flow based hollow-fiber blood-brain barrier in vitro model with immortalised cell line PBMEC/C1-2

Gerhard Ecker (Contributor)

25 Jun 2006

Activity: Talks and presentations › Talk or oral contribution › Other

P-glycoprotein - From target to antitarget

Gerhard Ecker (Invited speaker)

7 Apr 2006

Activity: Talks and presentations › Talk or oral contribution › Other

Pharmacoinformatic approaches to target polyspecific proteins

Gerhard Ecker (Invited speaker)

21 Feb 2006

Activity: Talks and presentations › Talk or oral contribution › Other

Add medical genetic solutions to RESOLUTE

Ecker, G., Dangl, A., Colas, C., Huang, J., Digles, D. & Schwarzenböck, M.

1/06/21 → 31/05/23

Project: Research funding

RISK-HUNT3R: RISK assessment of chemicals integrating HUman centric Next generation Testing strategies promoting the 3Rs

Ecker, G., Dangl, A. & Schwarzenböck, M.

1/06/21 → 31/05/26

Project: Research funding

ReSOLUTE: Research Empowerment on Solute Carriers

Ecker, G., Dangl, A., Digles, D., Colas, C. & Schwarzenböck, M.

1/07/18 → 31/12/23

Project: Research funding

eTRANSAFE: Enhancing TRANslational SAFEty Assessment through Integrative Knowledge Management

Ecker, G., Dangl, A., Hemmerich, J., Smajic, A., Grandits, M., Kaiser, F. & Schwarzenböck, M.

1/09/17 → 28/02/23

Project: Research funding

FAIRness for Life Science Data in Austria

Ecker, G.

1/06/17 → 31/12/19

Project: Research funding

TransQST: Translational quantitative systems toxicology to improve the understanding of the safety of medicines

Ecker, G., Grandits, M., Dangl, A., Füzi, B. & Schwarzenböck, M.

1/01/17 → 30/06/22

Project: Research funding

EU-ToxRisk: EU-ToxRisk

Ecker, G., Grandits, M., Dangl, A., Zdrazil, B., Jain, S. & Schwarzenböck, M.

1/01/16 → 31/12/21

Project: Research funding

Liganden für das alpha+/ beta-

Ecker, G.

3/12/14 → 3/12/17

Project: Research funding

K4DD

Ecker, G., Grandits, M. & Dangl, A.

1/11/12 → 31/10/17

Project: Research funding

Open PHACTS

Ecker, G. & Dangl, A.

1/03/11 → 28/02/16

Project: Research funding

Molecular Drug Targets

Hering, S., Ecker, G., Maulide, N., Weinzinger, A. & Gonzalez Herrero, L.

1/12/10 → 31/12/22

Project: Research funding

e-Tox

Ecker, G. & Grandits, M.

1/01/10 → 31/12/16

Project: Research funding

Arzneistoff-Transporter Interak

Ecker, G.

6/12/07 → 31/12/18

Project: Research funding

EUROPIN

Ecker, G.

1/10/07 → 30/09/09

Project: Research funding

Deskriptoren/Wirkstoffentwickl.

Ecker, G.

1/12/06 → 31/12/09

Project: Research funding

Department of Pharmaceutical Sciences

Josef-Holaubek-Platz 2 (UZA II)
1090 Wien
Room: 2E405

T: +43-1-4277-55110

gerhard.f.ecker@univie.ac.at